This advert is not available!
The University of Oulu is a multidisciplinary, international research university, with about 3,600 employees who produce new knowledge based on high-standards research and provide research based education to build a more sustainable, smarter, and more humane world. The University of Oulu community has about 17,000 people in total. Our northern scientific community operates globally and creates conditions for the emergence of innovations.
We are now looking for a
to the education pilot in precision cancer medicine (iCANDOC) to join our Colorectal Cancer Research Group in Translational Medicine Research Unit at the Faculty of Medicine of University of Oulu.
The Faculty of Medicine, an integral part of the Kontinkangas Life Sciences Campus, is situated next to Oulu University Hospital and is a unique combination of partners in research, education, health services, and business.
Colorectal cancer, the third most common cancer, is a highly heterogeneous disease at both molecular and morphological levels. Its progression is shaped by complex interactions between tumor cells and the surrounding stromal and immune cells. Our research group focuses on three key areas: (1) identifying the factors that drive colorectal cancer heterogeneity, (2) uncovering the role of tumor-host interactions in disease progression, and (3) developing novel biomarkers to advance precision medicine.
As a doctoral researcher in our group, you will participate in the analysis of large colorectal cancer cohorts. You will apply techniques such as multiplex immunohistochemistry, in situ hybridization, spatial transcriptomics to uncover the molecular variations that drive tumor phenotypes in colorectal cancer. You will apply data analysis methods and bioinformatics analyses to analyze large-scale molecular data. The findings of the project could refine future tumor classification systems, aid in developing novel biomarkers, and enable more personalized treatment approaches.
The doctoral training will give you a strong background for future tissue-based research related to cancer biology, tumor immunology, and bioinformatics. It will offer rich opportunities for networking, mobility, and further career development after completing the PhD in three years.
In order to succeed and enjoy the position, we expect from you:
We also appreciate
Doctoral researchers selected in the pilot programme will by default be offered a three-year (36 month) fixed-term full-time employment contract by University of Oulu. These positions are available for highly motivated and talented researchers wishing to undertake and complete training for a research-focused doctoral degree, starting January 1, 2025 at the earliest. The selected applicants are expected to start their project no later than February 1, 2025. A six-month trial period is applied in the position.
The salary will be based on the levels 2-4 of the demand level chart for teaching and research staff of Finnish universities. In addition, a salary component based on personal work performance will be paid (maximum of 50 % of the job-specific component). Starting gross salary will be approx. 2500-2800 € per month (before taxes).
Interested? If yes, please apply by 23.10.2024 (23:59 Finnish local time) through our recruitment system.
The application should be written in English and include the following:
Only applications containing all relevant appendices and submitted through the online recruitment system will be considered. Applications received after the call deadline will not be considered.
We welcome applicants from all backgrounds, such as people of different ages, genders and lingual, cultural or minority groups.
If you have any further questions, please contact Juha Väyrynen (juha.vayrynen(at)oulu.fi).
Type of employment | Temporary position over 6 months |
---|---|
Contract type | Full time |
Number of positions | 1 |
Full-time equivalent | 100 % |
City | Oulu |
County | Pohjois-Pohjanmaa |
Country | Finland |
Reference number | 2024/458 |
Published | 23.Sep.2024 |
Last application date | 23.Oct.2024 |